Abstract
Abstract
Purpose
The aim of the prospective study was to assess changes during treatment and prognostic significance of cervical vascularization density in patients with cervical squamous cell carcinoma (SCC) staged II B and III B and to find relationship of cervical vascularization density with tumour diameter, grading, staging and age of patients.
Methods
The study group included 50 patients who underwent transvaginal Doppler ultrasonography prior to chemoradiotherapy, after external beam radiation therapy (EBRT) and 6 weeks after HDR brachytherapy. The colour Doppler (CD) vascularity index (CDVI) and the power Doppler (PD) vascularity index (PDVI) in cervical tumour were examined.
Results
CDVI and PDVI values decreased significantly during radiotherapy (0.13 (95% CI 0.09–0.16); 0.09 (95% CI 0.07–0.11) and 0.05 (95% CI 0.03–0.06) for CDVI (p < 0.001) and 0.26 (95% CI 0.22–0.31); 0.18 (95% CI 0.14–0.22) and 0.08 (95% CI 0.06–0.11) for PDVI (p < 0.001)). No statistically significant associations of CDVI and PDVI with tumour diameter, grading, staging and age of patients were found. The higher (above median) CDVI values before EBRT were associated with better OS (p = 0.041). The higher (above median) PDVI values before EBRT were associated with superior DFS (p = 0.011) and OS (p < 0.001). DFS and OS did not differ significantly regarding CDVI and PDVI values after EBRT and after the treatment.
Conclusions
In the study group, cervical vascularization density evaluated in CD and PD functions did not depend on tumour diameter, grading, staging and age of patients and decreased during radiotherapy. The prognosis for our patients with CDVI and PDVI before the treatment above the median value was better than compared to patients with these parameters below the median value.
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology,General Medicine
Reference24 articles.
1. The NCCN Clinical Practice Guidelines in Oncology Cervical Cancer (Version 1.2020). National Comprehensive Cancer Network, Inc., 2020. https://www.nccn.org/professionals/physician_gls/pdf/cervical.pdf. Accessed 4 Feb 2020
2. Marth C, Landoni F, Mahner S, McCormack M, Gonzalez-Martin A, Colombo N, ESMO Guidelines Committee (2018) Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 29(Suppl 4):vi262. https://doi.org/10.1093/annonc/mdy160
3. Cohen PA, Jhingran A, Oaknin A, Denny L (2019) Cervical cancer. Lancet 393:169–182. https://doi.org/10.1016/S0140-6736(18)32470-X
4. Gangopadhyay A (2020) Prognostic nutritional index and clinical response in locally advanced cervical cancer. Nutr Cancer. https://doi.org/10.1080/01635581.2020.1729820
5. Bremer GL, Tiebosch AT, van der Putten HW, Schouten HJ, de Haan J, Arends JW (1996) Tumor angiogenesis: an independent prognostic parameter in cervical cancer. Am J Obstet Gynecol 174:126–131. https://doi.org/10.1016/s0002-9378(96)70384-8
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献